Intelligent Clinical Trials 2024

Contributors Lead authors Acknowledgements Gavin Corcoran Chief Development Officer, Formation Bio Alban de La Sablière Chief Operating Officer, Owkin Eric Durand Chief Data Science Officer, Owkin Andrew Giessel Executive Director of Artificial Intelligence Engineering, Moderna Jennifer Goldsack Chief Executive Officer, Digital Medicine Society (DiMe) Shakthi M. Nagappan Head, C4IR Telangana Daniel-Timon Spanka Product Manager Data Analytics, Alcedis – a HUMA Company Eric Sutherland Senior Health Economist, Organisation for Economic Co-operation and Development (OECD) Paul Christian Wallbott Data Scientist, Alcedis – a HUMA Company Henry Wei Head of Development Innovation, Regeneron Alex Zhavoronkov Chief Executive Officer, Insilico MedicineThanks are extended to the following individuals for their invaluable contributions to this paper: ZS Nicolas Zimmerman Senior Content Strategy Lead World Economic Forum Andy Moose Head of Initiatives, Centre for Health and Healthcare Antonio Spina Lead, Digital and AI Health, Centre for Health and HealthcareWorld Economic Forum Jitka Kolarova Lead, Health and Healthcare Innovations, Centre for Health and HealthcareZS Alex Anokhin Health and Healthcare Innovations Dan Reiss Principal Intelligent Clinical Trials: Using Generative AI to Fast-Track Therapeutic Innovations 17